Percutaneous tibial nerve stimulation

Results: 49



#Item
21Medical specialties / Surgical specialties / Overactive bladder / Botulinum toxin / Urge incontinence / Urology / Urodynamic testing / Percutaneous tibial nerve stimulation / Spasmodic torticollis / Medicine / Incontinence / Muscarinic antagonists

1272 Consultation Decision Analytic Protocol (DAP) to guide the assessment of intravesical injection of BOTOX® (botulinum toxin) for the treatment of urinary incontinence due to idiopathic detrusor overactivity (IDO) Oc

Add to Reading List

Source URL: www.msac.gov.au

Language: English - Date: 2014-11-06 23:50:01
22Fecal incontinence / Percutaneous tibial nerve stimulation

Microsoft Word - MSAC[removed]Artifical Bowel Sphincter.doc

Add to Reading List

Source URL: www.msac.gov.au

Language: English - Date: 2014-08-08 00:29:12
23Urinary incontinence / Urinary urgency / Overactive bladder / Acupuncture / Frequent urination / Urinary bladder / Urination / Percutaneous tibial nerve stimulation / Urge incontinence / Medicine / Anatomy / Incontinence

Asheville Center For Chinese Medicine

Add to Reading List

Source URL: www.acupunctureasheville.com

Language: English - Date: 2009-04-13 05:54:11
24Incontinence / Prolapse / Fecal incontinence / Urinary urgency / Gynaecology / Urology / Percutaneous tibial nerve stimulation / Medicine / Health / Urinary incontinence

ADULT CONTINENCE TRIAGE REFERRAL FORM Complete this form in full to ensure patients are correctly triaged by the continence specialist nurse & physiotherapist Please refer to the district nurse if the patient is housebou

Add to Reading List

Source URL: www.clch.nhs.uk

Language: English - Date: 2012-11-13 10:52:44
25Overactive bladder / Muscarinic antagonists / Astellas Pharma / Solifenacin / Urinary incontinence / Frequent urination / Urge incontinence / Urination / Percutaneous tibial nerve stimulation / Medicine / Urology / Incontinence

June 18, 2010 Application for Mirabegron (YM178), a Treatment for OAB, in Japan Tokyo, Japan, June 18, [removed]Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafumi Nogimori) announced th

Add to Reading List

Source URL: www.astellas.com

Language: English - Date: 2010-06-17 22:05:31
26Overactive bladder / Urodynamic testing / Urinary incontinence / Urinary retention / Astellas Pharma / Urinary bladder / National Association For Continence / Frequent urination / Percutaneous tibial nerve stimulation / Medicine / Urology / Incontinence

MYRBETRIQ™ (mirabegron), Overactive Bladder Treatment from Astellas, Now Available Through U.S. Pharmacies NORTHBROOK, Ill., Oct. 22, 2012 – Astellas Pharma US, Inc. (“Astellas”), a U.S. subsidiary of Tokyobased

Add to Reading List

Source URL: www.astellas.com

Language: English - Date: 2012-10-22 19:12:22
27Astellas Pharma / Tolterodine / Benign prostatic hyperplasia / Urination / Urinary retention / Prostate cancer / Percutaneous tibial nerve stimulation / Medicine / Muscarinic antagonists / Overactive bladder

PRESS RELEASE For immediate release MIRABEGRON RECEIVES POSITIVE CHMP OPINION FOR TREATMENT OF OVERACTIVE BLADDER SYMPTOMS Chertsey, UK, 19th October[removed]ASTELLAS PHARMA EUROPE Ltd. announced today that the Committee f

Add to Reading List

Source URL: www.astellas.com

Language: English - Date: 2012-10-21 18:34:10
28Tolterodine / Chemistry / Overactive bladder / Organochlorides / Organic chemistry / Amines / Percutaneous tibial nerve stimulation / Muscarinic antagonists / Phenols / Pfizer

Advisory Committee Briefing Document

Add to Reading List

Source URL: www.fda.gov

Language: English
29Clinical research / Pharmacology / Organochlorides / Amines / Experimental psychology / Placebo / Clinical trial / Tapentadol / Percutaneous tibial nerve stimulation / Chemistry / Medicine / Organic chemistry

Summary of Safety and Efficacy as Basis for AC Committee Briefing Book

Add to Reading List

Source URL: www.fda.gov

Language: English
30Overactive bladder / Urodynamic testing / Urinary incontinence / Urinary retention / Astellas Pharma / Urinary bladder / National Association For Continence / Frequent urination / Percutaneous tibial nerve stimulation / Medicine / Urology / Incontinence

MYRBETRIQ™ (mirabegron), Overactive Bladder Treatment from Astellas, Now Available Through U.S. Pharmacies NORTHBROOK, Ill., Oct. 22, 2012 – Astellas Pharma US, Inc. (“Astellas”), a U.S. subsidiary of Tokyobased

Add to Reading List

Source URL: www.simonfoundation.org

Language: English - Date: 2012-10-23 22:18:12
UPDATE